Open AccessTBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
Author(s) -
Lisa A. Carey,
Hope S. Rugo,
P. Kelly Marcom,
Erik Mayer,
Francisco J. Esteva,
Cynthia X. Ma,
Minetta C. Liu,
Anna Maria Storniolo,
Mothaffar F. Rimawi,
Andrés Forero-Torres,
Antonio C. Wolff,
Timothy J. Hobday,
Anastasia Ivanova,
Wing-Keung Chiu,
Madlyn Ferraro,
Emily Burrows,
Philip S. Bernard,
Katherine A. Hoadley,
Charles M. Perou,
Eric P. Winer
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/yrss-qx89
Subject(s) - cetuximab , triple negative breast cancer , carboplatin , oncology , medicine , breast cancer , stage (stratigraphy) , chemotherapy , cancer , cisplatin , biology , colorectal cancer , paleontology